相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Whole-genome sequencing facilitates patient-specific quantitative PCR-based minimal residual disease monitoring in acute lymphoblastic leukaemia, neuroblastoma and Ewing sarcoma
Vinod Vijay Subhash et al.
BRITISH JOURNAL OF CANCER (2022)
Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocols
Gunnar Cario et al.
HAEMATOLOGICA (2020)
IKZF1 deletions in pediatric acute lymphoblastic leukemia: still a poor prognostic marker?
Martin Stanulla et al.
BLOOD (2020)
Adjuvant tyrosine kinase inhibitor therapy improves outcome for children and adolescents with acute lymphoblastic leukaemia who have an ABL-class fusion
Anthony V. Moorman et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer
Marie Wong et al.
NATURE MEDICINE (2020)
Outcomes of paediatric patients with B-cell acute lymphocytic leukaemia with ABL-class fusion in the pre-tyrosine-kinase inhibitor era: a multicentre, retrospective, cohort study
Monique L den Boer et al.
Lancet Haematology (2020)
Efficacy of tyrosine kinase inhibitors in Ph-like acute lymphoblastic leukemia harboring ABL-class rearrangements
Ilaria Tanasi et al.
BLOOD (2019)
Validation of the United Kingdom copy-number alteration classifier in 3239 children with B-cell precursor ALL
Lina Hamadeh et al.
BLOOD ADVANCES (2019)
A risk score including microdeletions improves relapse prediction for standard and medium risk precursor B-cell acute lymphoblastic leukaemia in children
Rosemary Sutton et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
GRIDSS: sensitive and specific genomic rearrangement detection using positional de Bruijn graph assembly
Daniel L. Cameron et al.
GENOME RESEARCH (2017)
High prevalence of relapse in children with Philadelphia-like acute lymphoblastic leukemia despite risk-adapted treatment
Susan L. Heatley et al.
HAEMATOLOGICA (2017)
High prevalence of relapse in children with Philadelphia-like acute lymphoblastic leukemia despite risk-adapted treatment
Susan L. Heatley et al.
HAEMATOLOGICA (2017)
Monitoring of childhood ALL using BCR-ABL1 genomic breakpoints identifies a subgroup with CML-like biology
Lenka Hovorkova et al.
BLOOD (2017)
Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: an international collaborative study
J. M. Boer et al.
LEUKEMIA (2016)
Integration of genetic and clinical risk factors improves prognostication in relapsed childhood B-cell precursor acute lymphoblastic leukemia
Julie A. E. Irving et al.
BLOOD (2016)
Persistent MRD before and after allogeneic BMT predicts relapse in children with acute lymphoblastic leukaemia
Rosemary Sutton et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group Study AALL0031
K. R. Schultz et al.
LEUKEMIA (2014)
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
K. G. Roberts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL
Arian van der Veer et al.
BLOOD (2013)
Breakpoint-specific multiplex polymerase chain reaction allows the detection of IKZF1 intragenic deletions and minimal residual disease monitoring in B-cell precursor acute lymphoblastic leukemia
Aurelie Caye et al.
HAEMATOLOGICA (2013)
IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol
Petra Dorge et al.
HAEMATOLOGICA (2013)
What is the relevance of Ikaros gene deletions as a prognostic marker in pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia?
Chiara Palmi et al.
HAEMATOLOGICA (2013)
A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3
Pablo Cingolani et al.
FLY (2012)
Highly sensitive MRD tests for ALL based on the IKZF1 Δ3-6 microdeletion
N. C. Venn et al.
LEUKEMIA (2012)
IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL
R. P. Kuiper et al.
LEUKEMIA (2010)
Prognostic significance of minimal residual disease in infants with acute lymphoblastic leukemia treated within the Interfant-99 protocol
V. H. J. Van der Velden et al.
LEUKEMIA (2009)
Deletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia.
Charles G. Mullighan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia
T. Flohr et al.
LEUKEMIA (2008)
Relapse in children with acute lymphoblastic leukemia involving selection of a preexisting drug-resistant subclone
Seoyeon Choi et al.
BLOOD (2007)
Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data
V. H. J. van der Velden et al.
LEUKEMIA (2007)
Monitoring minimal residual disease by quantification of genomic chromosomal breakpoint sequences in acute leukemias with MLL aberrations
T Burmeister et al.
LEUKEMIA (2006)
分享论文
